{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T14:59:31Z","timestamp":1649084371822},"reference-count":31,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6659","type":"journal-article","created":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T22:09:49Z","timestamp":1476482989000},"page":"3029-3034","source":"Crossref","is-referenced-by-count":1,"title":["Tumor Lysis-like Syndrome in Eosinophilic Disease of the Lung: A Case Report and Review of the Literature"],"prefix":"10.2169","volume":"55","author":[{"given":"Seiya","family":"Urae","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayori","family":"Tsuruoka","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Kuroya","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Shibagaki","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Seegmiller JE, Laster L, Howell RR. Biochemistry of uric acid and its relation to gout. N Engl J Med 268: 712-716, 1963.","DOI":"10.1056\/NEJM196303282681306"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127: 3-11, 2004.","DOI":"10.1111\/j.1365-2141.2004.05094.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med 364: 1844-1854, 2011.","DOI":"10.1056\/NEJMra0904569"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Abu-Alfa AK, Younes A. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management. Am J Kidney Dis 55: S1-S13, 2010.","DOI":"10.1053\/j.ajkd.2009.10.056"},{"key":"5","unstructured":"5. Baeksgaard L, S\u00f8rensen JB. Acute tumor lysis syndrome in solid tumors: a case report and review of the literature. Cancer Chemother Pharmacol 51: 187-192, 2003."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Coiffier B. Acute tumor lysis syndrome: a rare complication in the treatment of solid tumors. Onkologie 33: 498-499, 2010.","DOI":"10.1159\/000320581"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Liberopoulos EN, Kei AA, Elisaf MS. Lysis syndrome during therapy of visceral leishmaniasis. Infection 40: 121-123, 2012.","DOI":"10.1007\/s15010-011-0202-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ralph R, Adrogue HE, Dolson G, Ramanathan V. Acute renal failure due to tumor lysis syndrome in a HIV seropositive patient with Castleman&apos;s disease. Nephrol Dial Transplant 19: 1937, 2004.","DOI":"10.1093\/ndt\/gfh245"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lee KD, Lee KW, Choi IS, et al. Multicentric Castleman&apos;s disease complicated by tumor lysis syndrome. Ann Hematol 83: 722-725, 2004.","DOI":"10.1007\/s00277-004-0923-2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lee JH, Kwon KA, Lee S, et al. Multicentric Castleman disease complicated by tumor lysis syndrome after systemic chemotherapy. Leuk Res 34: e42-e45, 2010.","DOI":"10.1016\/j.leukres.2009.08.025"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Blanchet GV, Allen HF, Mehrotra SP, Richardson MW. The tumor lysis syndrome in a child with multicentric Castleman disease. J Pediatr Hematol Oncol 32: 247-249, 2010.","DOI":"10.1097\/MPH.0b013e3181cef45a"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Jaing TH, Hsueh C, Tain YL, Hung IJ, Hsia SH, Kao CC. Tumor lysis syndrome in an infant with Langerhans cell histiocytosis successfully treated using continuous arteriovenous hemofiltration. J Pediatr Hematol Oncol 23: 142-144, 2001.","DOI":"10.1097\/00043426-200102000-00016"},{"key":"13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000337553","volume":"224","author":"R Cavalli","year":"2012","unstructured":"13. Cavalli R, Buffon RB, de Souza M, Colli AM, Gelmetti C. Tumor lysis syndrome after propranolol therapy in ulcerative infantile hemangioma: rare complication or incidental finding? Dermatology 224: 106-109, 2012.","journal-title":"Dermatology","ISSN":"http:\/\/id.crossref.org\/issn\/1018-8665","issn-type":"print"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kato K, Matsui K, Hoshino M, et al. Tumor cell lysis syndrome resulting from transient abnormal myelopoiesis in a neonate with Down&apos;s syndrome. Pediatr Int 43: 84-86, 2001.","DOI":"10.1046\/j.1442-200x.2001.01333.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Abe Y, Mizuno K, Horie H, Mizutani K, Okimoto Y. Transient abnormal myelopoiesis complicated by tumor lysis syndrome. Pediatr Int 48: 489-492, 2006.","DOI":"10.1111\/j.1442-200X.2006.02237.x-i1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yang SS, Chau T, Dai MS, Lin SH. Steroid-induced tumor lysis syndrome in a patient with preleukemia. Clin Nephrol 59: 201-205, 2003.","DOI":"10.5414\/CNP59201"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Feng Y, Jiang T, Wang L. Hyperuricemia and acute kidney injury secondary to spontaneous tumor lysis syndrome in low risk myelodysplastic syndrome. BMC Nephrol 15: 164, 2014.","DOI":"10.1186\/1471-2369-15-164"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Cairo MS, Coiffier B, Reiter A, Younes A; TLS Expert Panel. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 149: 578-586, 2010.","DOI":"10.1111\/j.1365-2141.2010.08143.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mirrakhimov AE, Voore P, Khan M, Ali AM. Tumor lysis syndrome: A clinical review. World J Crit Care Med 4: 130-138, 2015.","DOI":"10.5492\/wjccm.v4.i2.130"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 26: 2767-2778, 2008.","DOI":"10.1200\/JCO.2007.15.0177"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sparano J, Ramirez M, Wiernik PH. Increasing recognition of corticosteroid-induced tumor lysis syndrome in non-Hodgkin&apos;s lymphoma. Cancer 65: 1072-1073, 1990.","DOI":"10.1002\/1097-0142(19900301)65:5<1072::AID-CNCR2820650504>3.0.CO;2-A"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tiley C, Grimwade D, Findlay M, et al. Tumour lysis following hydrocortisone prior to a blood product transfusion in T-cell acute lymphoblastic leukaemia. Leuk Lymphoma 8: 143-146, 1992.","DOI":"10.3109\/10428199209049828"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Coutinho AK, de O Santos M, Pinczowski H, Feher O, del Giglio A. Tumor lysis syndrome in a case of chronic lymphocytic leukemia induced by high-dose corticosteroids. Am J Hematol 54: 85-86, 1997.","DOI":"10.1002\/(SICI)1096-8652(199701)54:1<85::AID-AJH15>3.0.CO;2-9"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Vaisban E, Zaina A, Braester A, Manaster J, Horn Y. Acute tumor lysis syndrome induced by high-dose corticosteroids in a patient with chronic lymphatic leukemia. Ann Hematol 80: 314-315, 2001.","DOI":"10.1007\/s002770000276"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Duzova A, Cetin M, G\u00fcmr\u00fck F, Yetgin S. Acute tumour lysis syndrome following a single-dose corticosteroid in children with acute lymphoblastic leukaemia. Eur J Haematol 66: 404-407, 2001.","DOI":"10.1034\/j.1600-0609.2001.066006404.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Lerza R, Botta M, Barsotti B, et al. Dexamethazone-induced acute tumor lysis syndrome in a T-cell malignant lymphoma. Leuk Lymphoma 43: 1129-1132, 2002.","DOI":"10.1080\/10428190290021452"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kopterides P, Lignos M, Mavrou I, Armaganidis A. Steroid-induced tumor lysis syndrome in a patient with mycosis fungoides treated for presumed <i>Pneumocystis carinii<\/i> pneumonia. Am J Hematol 80: 309, 2005.","DOI":"10.1002\/ajh.20444"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kim JO, Jun DW, Tae HJ, et al. Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient. Clin Mol Hepatol 21: 85-88, 2015.","DOI":"10.3350\/cmh.2015.21.1.85"},{"key":"29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1025590308147","volume":"8","author":"A Druilhe","year":"2003","unstructured":"29. Druilhe A, L\u00e9tuv\u00e9 S, Pretolani M. Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis 8: 481-495, 2003.","journal-title":"APOPTOSIS","ISSN":"http:\/\/id.crossref.org\/issn\/1360-8185","issn-type":"print"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Walsh GM, Sexton DW, Blaylock MG. Corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inflammation in asthma. J Endocrinol 178: 37-43, 2003.","DOI":"10.1677\/joe.0.1780037"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Goldman SC, Holcenberg JS, Finklestein JZ. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 97: 2998-3003, 2001.","DOI":"10.1182\/blood.V97.10.2998"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/20\/55_55.6659\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:11:27Z","timestamp":1498353087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/20\/55_55.6659\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":31,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6659","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}